General Information |
Board Constituency: |
Private sector |
Is your organization legally registered in your country: |
Yes |
If yes, please enter your registration number: |
|
Organization Type - Primary: |
Private Sector |
Organization Type - Secondary: |
Company |
Organization Description: |
We are a small diagnostics company developing technology arising from university research. We currently sell IsoScreen, a point-of-care urine test to monitor isoniazid adherence. We are working with UK academic and NHS departments to evaluate and integrate the test into routine care. We are also working with academic departments in Toronto, Canada and in Tanzania. We are currently developing a rapid, point of care diagnostic for TB. |
|
Do you know about the UNHLM declaration: |
|
Other Organization Information |
Total number of staff in your organization: |
1 - 5 |
Number of full-time staff who are directly involved with TB: |
1 - 5 |
Number of part-time staff who are directly involved with TB: |
0 |
Number of volunteers who are directly involved with TB: |
0 |
|
How did you hear about the Stop TB Partnership: |
Attendance at a TB related event |
If you were informed or referred by another partner of the Stop TB Partnership please tell us who: |
|
Why do you wish join the Stop TB Partnership: |
Network with other partners |
|
Are you a member of a Stop TB national partnership: |
United Kingdom |
Are you in contact with your national TB programme: |
Yes |
Please tell us how your organization is contributing to your country's national TB control plan: |
|
|
Geographical Reach |
Which country is your headquarters located in: |
United Kingdom of Great Britain and Northern Ireland |
Which countries do you do operate in: (This includes countries you are conducting activities in) |
United Kingdom of Great Britain and Northern Ireland |